In a recently published Cell paper, Roth et al. report a CRISPR-based platform for developing T cell therapies that strategically combine a tumor-specific TCR with novel protein factors that potentiate antitumor function.

中文翻译：

---

筛选下一代T细胞疗法。

在最近发表的Cell论文中，Roth等人。报道了一个基于CRISPR的平台，用于开发T细胞疗法，该平台将肿瘤特异性TCR与增强抗肿瘤功能的新型蛋白质因子策略性地结合在一起。